Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - amisulpride, quantity: 100 mg/ml - oral liquid, solution - excipient ingredients: methyl hydroxybenzoate; hydrochloric acid; propyl hydroxybenzoate; purified water; potassium sorbate; saccharin sodium; gluconolactone; sodium gluconate; flavour - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - amisulpride, quantity: 400 mg - tablet, film coated - excipient ingredients: titanium dioxide; peg-40 stearate; magnesium stearate; lactose monohydrate; hypromellose; microcrystalline cellulose; sodium starch glycollate type a - the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorder) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominantly negative symptoms.

United States - English - NLM (National Library of Medicine)

washington homeopathic products - solidago - to relieve the symptoms of pain; low back and leg. indications: solidago   pain; low back and leg if symptoms persist/worsen or if pregnant/nursing, stop use and consult your practitioner.

United States - English - NLM (National Library of Medicine)

washington homeopathic products - solidago virgaurea - to relieve the symptoms of pain; low back and leg. indications: solidago pain; low back and leg if symptoms persist/worsen or if pregnant/nursing, consult your practitioner.

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - solidago virgaurea flowering top (unii: 5405k23s50) (solidago virgaurea flowering top - unii:5405k23s50), baptisia tinctoria root (unii: 5ef0hwi5wu) (baptisia tinctoria root - unii:5ef0hwi5wu), berberis vulgaris root bark (unii: 1th8q20j0u) (berberis vulgaris root bark - unii:1th8q20j0u), equisetum hyemale (unii: 59677rxh25) (equisetum hyemale - unii:59677rxh25), silver nitrate (unii: 95it3w8jze) (silver cation - unii:57n7b0k90a), lytta vesicatoria (unii: 3q034ro3bt) (lytta vesicatoria - unii:3q034ro3bt), c - solidago virgaurea flowering top 3 [hp_x] in 1 ml - temporary relief of symptoms such as headaches, mood swings, and fatigue.** ** these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration. temporary relief of symptoms such as headaches, mood swings, and fatigue.** ** these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.

United States - English - NLM (National Library of Medicine)

restivo chiropractic - solidago virgaurea flowering top (unii: 5405k23s50) (solidago virgaurea flowering top - unii:5405k23s50), baptisia tinctoria root (unii: 5ef0hwi5wu) (baptisia tinctoria root - unii:5ef0hwi5wu), berberis vulgaris root bark (unii: 1th8q20j0u) (berberis vulgaris root bark - unii:1th8q20j0u), equisetum hyemale (unii: 59677rxh25) (equisetum hyemale - unii:59677rxh25), silver nitrate (unii: 95it3w8jze) (silver cation - unii:57n7b0k90a), lytta vesicatoria (unii: 3q034ro3bt) (lytta vesicatoria - unii:3q034ro3bt), c - solidago virgaurea flowering top 3 [hp_x] in 1 ml - for the temporary relief of symptoms related to improper breakdown and excretion of allergenic substances, including headaches, mood disorders and fatigue. for the temporary relief of symptoms related to improper breakdown and excretion of allergenic substances, including headaches, mood disorders and fatigue.

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - solidago virgaurea flowering top (unii: 5405k23s50) (solidago virgaurea flowering top - unii:5405k23s50), baptisia tinctoria root (unii: 5ef0hwi5wu) (baptisia tinctoria root - unii:5ef0hwi5wu), berberis vulgaris root bark (unii: 1th8q20j0u) (berberis vulgaris root bark - unii:1th8q20j0u), equisetum hyemale (unii: 59677rxh25) (equisetum hyemale - unii:59677rxh25), silver nitrate (unii: 95it3w8jze) (silver cation - unii:57n7b0k90a), lytta vesicatoria (unii: 3q034ro3bt) (lytta vesicatoria - unii:3q034ro3bt), c - solidago virgaurea flowering top 3 [hp_x] in 1 ml - for the temporary relief of symptoms related to improper breakdown and excretion of allergenic substances, including headaches, mood disorders and fatigue. for the temporary relief of symptoms related to improper breakdown and excretion of allergenic substances, including headaches, mood disorders and fatigue.

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - solidago virgaurea flowering top (unii: 5405k23s50) (solidago virgaurea flowering top - unii:5405k23s50), asparagus (unii: z1ejp3037z) (asparagus - unii:z1ejp3037z), juniperus communis whole (unii: 464910t5n9) (juniperus communis whole - unii:464910t5n9), saw palmetto (unii: j7wwh9m8qs) (saw palmetto - unii:j7wwh9m8qs), arctostaphylos uva-ursi leaf (unii: 3m5v3d1x36) (arctostaphylos uva-ursi leaf - unii:3m5v3d1x36), berberis vulgaris root bark (unii: 1th8q20j0u) (berberis vulgaris root bark - unii:1th8q20j0 - solidago virgaurea flowering top 1 [hp_x] in 1 ml - for the temporary relief of symptoms related to kidney drainage, such as renal detox, swelling and fatigue.** **these statements are based upon traditional homeopathic practice. they have not been reviewed by the food and drug administration. for the temporary relief of symptoms related to kidney drainage, such as renal detox, swelling and fatigue.** **these statements are based upon traditional homeopathic practice. they have not been reviewed by the food and drug administration.

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - amisulpride 100 mg/ml;   - oral solution - 100 mg/ml - active: amisulpride 100 mg/ml   excipient: caramel hydrochloric acid methyl hydroxybenzoate potassium sorbate propyl hydroxybenzoate purified water sweetener gesweet 01002023 - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - amisulpride 100mg;  ;  ; amisulpride 100mg - tablet - 100 mg - active: amisulpride 100mg     excipient: hydrated silica lactose monohydrate magnesium stearate methylcellulose potato starch active: amisulpride 100mg excipient: hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose sodium starch glycolate - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.